News

McKesson has posted a net income of $348m for the fourth quarter of 2010, or $1.26 per diluted share, compared to $281m, or $1.01 per diluted share, for

The partnership will provide a synergy of combined solutions that will enable enhanced information exchange capabilities to increase the efficacy of the Regional Health Information Organization (RHIO) Financial

The solution will be used for the employed physicians of the Peninsula Regional Medical Group comprised of family medicine and specialty practices in Maryland, Delaware and Virginia, and

Required for new drug application (NDA) submission with the FDA, this ‘combination rule’ study compared the efficacy and safety profiles of MoxDuo IR against component doses of Morphine

Dr Bopanna will primarily be based in Bangalore, India, and he will also have an office at the Corporate HQ in North Hollywood, CA, USA. Prior to joining

Althea Technologies said that applications of this protein crystal technology range from therapeutics to protein purification and catalysis. The controlled release injectable technology involves protein crystallisation and complexation

Belatacept is an investigational agent under development by Bristol-Myers Squibb for the prophylaxis of organ rejection in adult patients receiving kidney transplants. The complete response letter requests the

As per the expanded agreement, in addition to antibody OMP-21M18, SynCo will fill batches of OncoMed’s investigational products, two additional antibodies in the OncoMed pipeline for use in

Ipsen has posted drug sales of EUR258m, an increase of 6.3%, compared to EUR242.8m for the year ago period. This performance was driven by strong specialty care sales,